EGFR and neoplasm: In this study, we enrolled thirty‐six EGFR‐mutant advanced lung adenocarcinoma patients, who were confirmed T790M‐positive based on tumour tissue genotyping assay, and investigated the clinical implications of serial analysis using a 1021 gene capture panel of ctDNA during osimertinib treatment.